Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aisabor AI"'
Autor:
Shrestha P; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Davis DA; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Jaeger HK; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Stream A; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Aisabor AI; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Yarchoan R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2021 Jan 07; Vol. 17 (1), pp. e1009091. Date of Electronic Publication: 2021 Jan 07 (Print Publication: 2021).
Autor:
Davis DA; HIV & AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Shrestha P; HIV & AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Aisabor AI; HIV & AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Stream A; HIV & AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Galli V; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Pise-Masison CA; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Tagawa T; HIV & AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Ziegelbauer JM; HIV & AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Franchini G; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Yarchoan R; HIV & AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2018 Dec 05; Vol. 8 (2), pp. e1546544. Date of Electronic Publication: 2018 Dec 05 (Print Publication: 2019).
Autor:
Davis DA; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Mishra S; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Anagho HA; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Aisabor AI; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Shrestha P; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Wang V; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Takamatsu Y; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Maeda K; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Mitsuya H; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Zeldis JB; Celgene Corp., Summit, NJ, USA., Yarchoan R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Publikováno v:
Oncotarget [Oncotarget] 2017 May 17; Vol. 8 (31), pp. 50342-50358. Date of Electronic Publication: 2017 May 17 (Print Publication: 2017).